Success Metrics

Clinical Success Rate
73.8%

Based on 31 completed trials

Completion Rate
74%(31/42)
Active Trials
9(15%)
Results Posted
68%(21 trials)
Terminated
11(18%)

Phase Distribution

Ph phase_4
6
10%
Ph phase_3
13
21%
Ph phase_1
11
18%
Ph phase_2
12
20%
Ph early_phase_1
6
10%
Ph not_applicable
10
16%

Phase Distribution

17

Early Stage

12

Mid Stage

19

Late Stage

Phase Distribution58 total trials
Early Phase 1First-in-human
6(10.3%)
Phase 1Safety & dosage
11(19.0%)
Phase 2Efficacy & side effects
12(20.7%)
Phase 3Large-scale testing
13(22.4%)
Phase 4Post-market surveillance
6(10.3%)
N/ANon-phased studies
10(17.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

63.3%

31 of 49 finished

Non-Completion Rate

36.7%

18 ended early

Currently Active

9

trials recruiting

Total Trials

61

all time

Status Distribution
Active(9)
Completed(31)
Terminated(18)
Other(3)

Detailed Status

Completed31
Terminated11
Recruiting9
Withdrawn7
unknown3

Development Timeline

Analytics

Development Status

Total Trials
61
Active
9
Success Rate
73.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (10.3%)
Phase 111 (19.0%)
Phase 212 (20.7%)
Phase 313 (22.4%)
Phase 46 (10.3%)
N/A10 (17.2%)

Trials by Status

unknown35%
recruiting915%
withdrawn711%
completed3151%
terminated1118%

Recent Activity

Clinical Trials (61)

Showing 20 of 61 trialsScroll for more
NCT02511028Phase 1

In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging

Completed
NCT03893045Phase 3

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Recruiting
NCT03619850Phase 3

A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Recruiting
NCT00707876Phase 2

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

Completed
NCT07461948Phase 3

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

Recruiting
NCT03270059Phase 2

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Recruiting
NCT04278651Phase 4

Early Antenatal Support for Iron Deficiency Anemia

Recruiting
NCT01374919Not Applicable

Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia

Completed
NCT04268849Phase 3

Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

Recruiting
NCT03347617Phase 2

Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma

Terminated
NCT02791568

Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation

Completed
NCT06440408Phase 1

Calculating Wall Shear Stress in Infant Pulmonary Veins

Recruiting
NCT02070705Not Applicable

DCE MRI in Patients With Pancreatic Cancer

Terminated
NCT05811377Early Phase 1

Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay

Completed
NCT06483061Phase 2

Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy

Recruiting
NCT02631733Phase 1

Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors

Completed
NCT01542879Phase 1

Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

Recruiting
NCT00659776Phase 2

MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation

Terminated
NCT04205266Phase 4

IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

Unknown
NCT00659126Phase 2

Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
61